}

Tender For E-Tender For The Procurement Of Anticancer Drugs For The Year 2024-25, thiruvananthapuram-Kerala

Kerala Medical Services Corporation Limited has published Tender For E-Tender For The Procurement Of Anticancer Drugs For The Year 2024-25. Submission Date for this Tender is 29-01-2024. Medicine Tenders in thiruvananthapuram Kerala. Bidders can get complete Tender details and download the document.




Tender Notice

41483064
Corrigendum : Tender For E-Tender For The Procurement Of Anticancer Drugs For The Year 2024-25
Open Tender
Indian
Kerala
thiruvananthapuram
29-01-2024

Tender Details

E-Tender For The Procurement Of Anticancer Drugs For The Year 2024-25 , Abiraterone Acetate Tab Ip 250 Mg , Afatinib Tab 30 Mg , Anastrazole Tab Ip 1Mg , Axitinib Tab 5 Mg , Azathioprine Tab Ip 50 Mg , Bendamustine Inj Ip 100Mg , Bicalutamide Tab Ip 50Mg , Bleomycin Inj Ip 15 Units , Bortezomib Inj Ip 2Mg , Cabozantinib Tab20mg , Capecitabine Tab Ip 500Mg , Ceritinib Cap 150 Mg , Cetuximab Inj 100Mg , Cyclophosphamide Tab Ip 50Mg , Cytarabine Inj Ip/Bp 100Mg , Dacarbazine Inj Ip/Usp 200Mg , Dactinomycin Inj 0.5 Mg/3Ml , Daunorubicin Inj Ip 20Mg , Denosumab Inj 120 Mg , Dexamethasone Tab Ip 8Mg , Dexamethasone Tab Ip 4 Mg , Doxorubicin (Pegylated Liposomal) Inj 50 Mg , Doxorubicin Liposomal Inj 20Mg , Enzalutamide Cap 80 Mg , Eribulin Inj 0.44 Mg/Ml , Etoposide Cap Ip 50Mg , Etoposide Inj Ip 100Mg , Exemestane Tab Ip 25 Mg , Ferric Carboxymaltose Inj 1Gm/ 20 Ml , Filgrastim Inj Ip 300Mcg , Fludarabine Phosphate Inj Ip/ Usp 50 Mg , Fulvestrant Inj 250 Mg , Gefitinib Tab Ip 250Mg , Ibandronate Tab 50 Mg , L.Asparaginase Inj 5000Iu , Lapatinib Tab Ip 250 Mg , Lenvatinib Cap 4 Mg , Letrozole Tab Ip/Usp 2.5Mg , Megestrol Acetate Tab Ip/Bp/Usp 40 Mg , Melphalan Tab Ip 5Mg , Mercaptopurine Tab Ip 50 Mg , Mesna Inj 200Mg , Methotrexate Inj (Intrathecal, Preservative Free) 15Mg , Methotrexate Tab Ip 2.5Mg , Mitomycin For Inj Ip/Usp 10 Mg , Mitoxantrone Infusion Bp/Usp 20 Mg , Paclitaxel Nanoparticle Inj 100Mg , Pazopanib Tab 400 Mg , Pegfilgrastim Inj 6Mg , Pomalidomide Cap 2 Mg , Procarbazine Hcl Cap Ip 50 Mg , Protein Bound Paclitaxel Inj 100 Mg , Rasburicase Inj 1.5 Mg , Regorafenib Tab 40 Mg , Rucaparib Tab 300 Mg , Sorafenib Tosylate Tab Ip 200Mg , Sunitinib Cap 12.5 Mg , Tamoxifen Tab Ip 20Mg , Tegafur +Uracil Cap 100 Mg + 224 , Thalidomide Cap Usp 100Mg , Vinblastine Sulphate Inj Ip 10Mg , Zoledronic Acid Inj Ip 4Mg , Bevacizumab Inj 100Mg , Bevacizumab Inj 400Mg , Carboplatin Inj Ip 150Mg , Carboplatin Inj Ip 450Mg , Carfilzomib Inj 30Mg , Carfilzomib Inj 60Mg , Cisplatin Inj Ip 10Mg , Cisplatin Inj Ip 50Mg , Cyclophosphamide Inj Ip 200Mg , Cyclophosphamide Inj Ip 500Mg , Cyclophosphamide Inj Ip 1 Gm , Dasatinib Tab 20 Mg , Dasatinib Tab 50 Mg , Decitabine Inj 50 Mg , Decitabine Inj 30Mg , Docetaxel Inj Ip 20Mg , Docetaxel Inj Ip 80Mg , Docetaxel Inj Ip 120 Mg , Doxorubicin Inj (Lyophilised) Ip 10Mg , Doxorubicin Inj (Lyophilised) Ip 50Mg , Epirubicin Inj Ip 10Mg , Epirubicin Inj Ip 50Mg , Erlotinib Tab Ip 100 Mg , Erlotinib Tab Ip 150 Mg , Everolimus Tab 10 Mg , Everolimus Tab 5Mg , Flurouracil Inj Ip 500Mg , Flurouracil Inj Ip 250Mg , Gemcitabine Inj Ip 200Mg , Gemcitabine Inj Ip 1Gm , Ifosfamide With Mesna Inj 1Gm , Ifosfamide With Mesna Inj 2Gm , Imatinib Tab Ip 100Mg , Imatinib Tab Ip 400Mg , Irinotecan Inj Ip 40Mg , Irinotecan Inj Ip 100Mg , Lenalidomide Cap 10Mg , Lenalidomide Cap 25Mg , Lenalidomide Cap 5Mg , Leucovorin Calcium Inj Ip 15Mg , Leucovorin Calcium Inj Ip 50Mg , Leuprolide Acetate Inj 3.75Mg , Leuprolide Acetate Inj 11.25 Mg , Leuprolide Acetate Inj 22.5 Mg , Methotrexateinj Ip 50Mg , Methotrexateinj Ip 500 Mg , Nilotinib Cap 150 Mg , Nilotinib Cap 200 Mg , Octreotideinj 30 Mg , Octreotideinj 20Mg , Oxaliplatin Inj Ip 50Mg , Oxaliplatin Inj Ip 100Mg , Paclitaxel Inj Ip 30Mg , Paclitaxel Inj Ip With Codon Set 100Mg , Paclitaxel Inj Ip With Codon Set 260Mg , Pemetrexed Inj Ip 100Mg , Pemetrexed Inj Ip 500Mg , Rituximab Inj 100Mg , Rituximab Inj 500Mg , Temozolomide Cap Ip 100Mg , Temozolomide Cap Ip 250 Mg , Trastuzumab Inj 440 Mg , Trastuzumab Inj 150 Mg , Vincristine Sulphate Inj Ip/Usp 1Mg , Vincristine Sulphate Inj Ip/Usp 2Mg

Corrigendum Details

Sr No CorrigendumDate Corrignedum CorrigendumType NewSubmissionDate
1 08-Jan-2024 Prebid meeting Technical Bid 22-01-2024
2 20-Jan-2024 Time Extension Notice Date 29-01-2024

Key Value

Document Fees
INR 29500 /-
EMD
INR 50000.0 /-
Tender Value
Refer document
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
Tell us about your Product / Services,
We will Find Tenders for you

Copyright © 2024 · All Rights Reserved. Terms of Usage | Privacy Policy

For Tender Information Services Visit : TenderDetail